Sean Lee CFA
Stock Analyst at H.C. Wainwright
(0.68)
# 3,869
Out of 4,407 analysts
254
Total ratings
31.2%
Success rate
-1.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SENS Senseonics Holdings | Reiterated: Buy | $14 | $7.18 | +94.99% | 8 | Jun 8, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $18 | $14.28 | +26.05% | 12 | Jun 4, 2026 | |
| DWTX Dogwood Therapeutics | Reiterated: Buy | $12 | $1.54 | +679.22% | 25 | May 19, 2026 | |
| CRVS Corvus Pharmaceuticals | Reiterated: Buy | $27 | $11.93 | +126.32% | 8 | May 15, 2026 | |
| CTSO Cytosorbents | Reiterated: Hold | $0.75 | $0.3998 | +87.59% | 30 | May 14, 2026 | |
| MYO Myomo | Reiterated: Buy | $5 | $1.15 | +334.78% | 9 | May 8, 2026 | |
| ATEC Alphatec Holdings | Reiterated: Buy | $24 | $8.28 | +189.86% | 31 | May 7, 2026 | |
| NVAX Novavax | Reiterated: Buy | $16 | $8.88 | +80.18% | 6 | Apr 21, 2026 | |
| AKTX Akari Therapeutics, | Reiterated: Buy | $27 | $13.40 | +101.49% | 4 | Apr 21, 2026 | |
| PSTV Plus Therapeutics | Reiterated: Buy | $25 | $5.01 | +399.00% | 28 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.20 | +1,900.00% | 20 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $4.10 | +241.46% | 35 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €14.00 | $3.89 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.76 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $59.59 | n/a | 18 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Mar 21, 2025 |
Senseonics Holdings
Jun 8, 2026
Reiterated: Buy
Price Target: $14
Current: $7.18
Upside: +94.99%
Kazia Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $14.28
Upside: +26.05%
Dogwood Therapeutics
May 19, 2026
Reiterated: Buy
Price Target: $12
Current: $1.54
Upside: +679.22%
Corvus Pharmaceuticals
May 15, 2026
Reiterated: Buy
Price Target: $27
Current: $11.93
Upside: +126.32%
Cytosorbents
May 14, 2026
Reiterated: Hold
Price Target: $0.75
Current: $0.3998
Upside: +87.59%
Myomo
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $1.15
Upside: +334.78%
Alphatec Holdings
May 7, 2026
Reiterated: Buy
Price Target: $24
Current: $8.28
Upside: +189.86%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $8.88
Upside: +80.18%
Akari Therapeutics,
Apr 21, 2026
Reiterated: Buy
Price Target: $27
Current: $13.40
Upside: +101.49%
Plus Therapeutics
Mar 16, 2026
Reiterated: Buy
Price Target: $25
Current: $5.01
Upside: +399.00%
Dec 9, 2025
Maintained: Buy
Price Target: $4
Current: $0.20
Upside: +1,900.00%
Nov 5, 2025
Reiterated: Buy
Price Target: $14
Current: $4.10
Upside: +241.46%
May 7, 2025
Maintained: Buy
Price Target: €14.00
Current: $3.89
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $11
Current: $1.76
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $40
Current: $59.59
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a